Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Revenue

In the year 2023, Harvard Bioscience had annual revenue of $112.25M, a decrease of -0.96%. Revenue in the quarter ending December 31, 2023 was $28.15M, a -0.96% decrease year-over-year.

• Revenue (ttm): $112.25M
• Revenue Growth: -0.96%
• P/S Ratio: 1.48
• Revenue / Employee: $287,084
• Employees: 391
• Market Cap: 165.79M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	112.25M	-1.09M	-0.96%
Dec 31, 2022	113.34M	-5.57M	-4.68%
Dec 31, 2021	118.90M	16.80M	16.46%
Dec 31, 2020	102.10M	-14.08M	-12.12%
Dec 31, 2019	116.18M	-4.60M	-3.81%
Dec 31, 2018	120.77M	43.37M	56.02%
Dec 31, 2017	77.41M	-27.11M	-25.94%
Dec 31, 2016	104.52M	-4.14M	-3.81%
Dec 31, 2015	108.66M	1,000.00	0.00%
Dec 31, 2014	108.66M	3.49M	3.32%
Dec 31, 2013	105.17M	-6.00M	-5.40%
Dec 31, 2012	111.17M	2.31M	2.12%
Dec 31, 2011	108.86M	685.00K	0.63%
Dec 31, 2010	108.18M	22.41M	26.12%
Dec 31, 2009	85.77M	-2.28M	-2.59%
Dec 31, 2008	88.05M	4.64M	5.57%
Dec 31, 2007	83.41M	7.23M	9.49%
Dec 31, 2006	76.18M	8.75M	12.98%
Dec 31, 2005	67.43M	2.69M	4.15%
Dec 31, 2004	64.75M	12.72M	24.45%
Dec 31, 2003	52.02M	-5.36M	-9.33%
Dec 31, 2002	57.38M	16.51M	40.40%
Dec 31, 2001	40.87M	10.29M	33.67%
Dec 31, 2000	30.57M	4.40M	16.80%
Dec 31, 1999	26.18M	14.02M	115.38%
Dec 31, 1998	12.15M	689.87K	6.02%
Dec 31, 1997	11.46M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.